Literature DB >> 12223025

Spontaneous "second wind" and glucose-induced second "second wind" in McArdle disease: oxidative mechanisms.

Ronald G Haller1, John Vissing.   

Abstract

BACKGROUND: Blocked glycogen breakdown in McArdle disease impairs oxidative as well as anaerobic metabolism, but the contribution of impaired oxidative phosphorylation to everyday symptoms of McArdle disease remains poorly defined.
OBJECTIVE: To evaluate the oxidative implications of the spontaneous second wind and variables that influence the development of this typical feature of McArdle disease.
DESIGN: Assessment of exercise and oxidative capacity (.VO(2)) before and after the spontaneous "second wind" and with a glucose infusion after a spontaneous second wind. PATIENTS: Eight patients with complete myophosphorylase deficiency and 1 unique patient with 3% of normal myophosphorylase activity. MAIN OUTCOME MEASURES: Work capacity,.VO(2), heart rate, cardiac output.
RESULTS: All patients with complete myophosphorylase deficiency (1) had low peak.VO(2) (mean +/- SD, 13.0 +/- 2.0 mL. kg(-1). min(-1)) in the first 6 to 8 minutes of exercise; (2) achieved a spontaneous second wind with increased exercise capacity between 8 and 12 minutes of exercise due to a more than 25% increase in peak.VO(2) (16.5 +/- 3.1 mL. kg(-1). min(-1)); and (3) with glucose infusion after a spontaneous second wind, experienced a further more than 20% increase in oxidative capacity (.VO(2), 19.9 +/- 3.9 mL. kg(-1). min(-1)). In the patient with residual myophosphorylase,.VO(2) (22.2 mL. kg(-1). min(-1)) in the first 6 to 8 minutes of exercise was approximately 2-fold higher than the mean of patients lacking myophosphorylase, and no significant improvement in exercise and oxidative capacity accompanied prolonged exercise or glucose infusion.
CONCLUSIONS: First, the spontaneous second wind and the glucose-induced second second wind in McArdle disease are due to substrate-dependent increases in muscle oxidative capacity. Second, by providing glycogen-derived pyruvate, a small amount of residual myophosphorylase activity normalizes the oxidative deficit of complete myophosphorylase deficiency and virtually eliminates the spontaneous second wind and glucose-induced second second wind.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223025     DOI: 10.1001/archneur.59.9.1395

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  34 in total

Review 1.  Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V).

Authors:  Rosaline Quinlivan; Andrea Martinuzzi; Benedikt Schoser
Journal:  Cochrane Database Syst Rev       Date:  2014-11-12

Review 2.  A diagnostic algorithm for metabolic myopathies.

Authors:  Andres Berardo; Salvatore DiMauro; Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

Review 3.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

4.  Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.

Authors:  Astrid Brull; Noemí de Luna; Albert Blanco-Grau; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Ramon Martí; Antoni L Andreu; Tomàs Pinós
Journal:  J Physiol       Date:  2015-05-18       Impact factor: 5.182

5.  A sugary cocktail for McArdle disease.

Authors:  Michio Hirano
Journal:  Curr Neurol Neurosci Rep       Date:  2005-02       Impact factor: 5.081

Review 6.  Molecular genetics of McArdle's disease.

Authors:  G Nogales-Gadea; J Arenas; A L Andreu
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

7.  Metabolic profiles of exercise in patients with McArdle disease or mitochondrial myopathy.

Authors:  Nigel F Delaney; Rohit Sharma; Laura Tadvalkar; Clary B Clish; Ronald G Haller; Vamsi K Mootha
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

Review 8.  Pharmacological and nutritional treatment trials in McArdle disease.

Authors:  R M Quinlivan; R J Beynon
Journal:  Acta Myol       Date:  2007-07

Review 9.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

10.  Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Authors:  Miguel García; Anna Pujol; Albert Ruzo; Efrén Riu; Jesús Ruberte; Anna Arbós; Anna Serafín; Beatriz Albella; Juan Emilio Felíu; Fátima Bosch
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.